Positive expectations contribute to the clinical benefits of the placebo effect1, 2. Such positive expectations are mediated by the brain's reward system3, 4; however, it remains unknown whether and how reward system activation affects the body's physiology and, specifically, immunity. Here we show that activation of the ventral tegmental area (VTA), a key component of the reward system, strengthens immunological host defense. We used 'designer receptors exclusively activated by designer drugs' (DREADDs) to directly activate dopaminergic neurons in the mouse VTA and characterized the subsequent immune response after exposure to bacteria (Escherichia coli), using time-of-flight mass cytometry (CyTOF) and functional assays. We found an increase in innate and adaptive immune responses that were manifested by enhanced antibacterial activity of monocytes and macrophages, reduced in vivo bacterial load and a heightened T cell response in the mouse model of delayed-type hypersensitivity. By chemically ablating the sympathetic nervous system (SNS), we showed that the reward system's effects on immunity are, at least partly, mediated by the SNS. Thus, our findings establish a causal relationship between the activity of the VTA and the immune response to bacterial infection.
At a glance
- Placebo use in the United Kingdom: results from a national survey of primary care practitioners. PLoS One 8, e58247 (2013). et al.
- Prescribing 'placebo treatments': results of national survey of US internists and rheumatologists. BMJ 337, a1938 (2008). , , , &
- Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293, 1164–1166 (2001). et al.
- Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 65, 220–231 (2008). et al.
- How placebos change the patient's brain. Neuropsychopharmacology 36, 339–354 (2011). , &
- Placebo controls: historical, methodological and general aspects. Phil. Trans. R. Soc. Lond. B 366, 1870–1878 (2011).
- Smile—it's in your blood! Biochem. Pharmacol. 91, 287–292 (2014). , &
- Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130, 601–630 (2004). &
- The immune system and happiness. Autoimmun. Rev. 5, 523–527 (2006).
- Social neuroscience and health: neurophysiological mechanisms linking social ties with physical health. Nat. Neurosci. 15, 669–674 (2012). &
- A functional genomic perspective on human well-being. Proc. Natl. Acad. Sci. USA 110, 13684–13689 (2013). et al.
- Modification of cytokine secretion following mild emotional stimuli. Neuroreport 6, 789–792 (1995). , , &
- Optimistic expectancies and cell-mediated immunity: the role of positive affect. Psychol. Sci. 21, 448–455 (2010). &
- Optimism is associated with mood, coping and immune change in response to stress. J. Pers. Soc. Psychol. 74, 1646–1655 (1998). , , &
- Optogenetic dissection of neural circuits underlying emotional valence and motivated behaviors. Brain Res. 1511, 73–92 (2013). , , &
- The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 14, 609–625 (2013). &
- Updating dopamine reward signals. Curr. Opin. Neurobiol. 23, 229–238 (2013).
- Evolving the lock to fit the key to create a family of G-protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. USA 104, 5163–5168 (2007). , , , &
- What's conditioned in conditioned place preference? Trends Pharmacol. Sci. 34, 162–166 (2013). , , &
- Natural neural projection dynamics underlying social behavior. Cell 157, 1535–1551 (2014). et al.
- Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687–696 (2011). et al.
- Effects of electrical stimulation of brain reward sites on release of dopamine in rat: an in vivo electrochemical study. Brain Res. Bull. 21, 319–324 (1988). , &
- Pharmacological treatment of Parkinson disease: a review. J. Am. Med. Assoc. 311, 1670–1683 (2014). &
- The sympathetic nerve—an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595–638 (2000). , , &
- Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol. Med. 17, 937–948 (2011). et al.
- Co-activation of renal sympathetic neurons and somatic motor neurons by chemical stimulation of the midbrain ventral tegmental area. J. Appl. Physiol. 110, 1342–1353 (2011). et al.
- Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 26, 199–288 (1974). &
- Time-dependent in vivo mesolimbic dopamine variations following antigenic challenge. Brain Res. 664, 225–230 (1994). , , &
- Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations. J. Pharmacol. Exp. Ther. 329, 1040–1047 (2009). , &
- Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats. Neuropsychopharmacology 29, 718–730 (2004). , &
- Oral sucrose stimulation increases accumbens dopamine in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R31–R37 (2004). , &
- New insights into the placebo and nocebo responses. Neuron 59, 195–206 (2008). , &
- National Research Council. Guide for the Care and Use of Laboratory Animals 8th edn. (The National Academies Press, 2011).
- Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons. Neuron 85, 429–438 (2015). et al.
- Remote control of neuronal signaling. Pharmacol. Rev. 63, 291–315 (2011). &
- Automated identification of stratifying signatures in cellular subpopulations. Proc. Natl. Acad. Sci. USA 111, E2770–E2777 (2014). , , , &
- A statistical framework for expression-based molecular classification in cancer. J. R. Stat. Soc. Series B Stat. Methodol. 64, 717–736 (2002). , , &
- Passive immunization of chicks against Escherichia coli. Avian Pathol. 19, 345–354 (1990). , , &
- Supplementary Text and Figures (9,455 KB)
Supplementary Tables 1–2 and Supplementary Figures 1–13